STK3 and Alzheimer disease: Previous studies confirmed that XMU-MP-1 selectively inhibited MST1 and MST2, enhanced their downstream YAP activation, with functional recovery promotion in spinal cord injured mice [28], demyelination prevention and neuroinflammation in EAE mice [49, 50], as well as cognitive function improvement in aged mice and AD model mice [51].